Author Correction: First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
- 作者单位
- Affiliations 1 State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing, China. 2 Harbin Medical University Cancer Hospital, Harbin, China. 3 Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China. 4 Department of Gastroenterology, Shandong Cancer Hospital, Jinan, China. 5 Shanxi Provincial Cancer Hospital, Taiyuan, China. 6 Tianjin Medical University Cancer Institute & Hospital, Tianjin, China. 7 Henan Cancer Hospital, Zhengzhou, China. 8 The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. 9 Liaoning Cancer Hospital & Institute, Shenyang, China. 10 The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China. 11 Yantai Yuhuangding Hospital, Yantai, China. 12 Fudan University Shanghai Cancer Center, Shanghai, China. 13 The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. 14 The First Affiliated Hospital of Bengbu Medical University, Bengbu, China. 15 Handan Central Hospital, Handan, China. 16 Changzhi People's Hospital, Changzhi, China. 17 The First Bethune Hospital of Jilin University, Changchun, China. 18 Nanjing Drum Tower Hospital, Nanjing, China. 19 The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 20 Fujian Cancer Hospital, Fuzhou, China. 21 Beijing Friendship Hospital, Capital Medical University, Beijing, China. 22 Qilu Hospital of Shandong University, Jinan, China. 23 Gansu Wuwei Tumour Hospital, Wuwei, China. 24 Nanyang Central Hospital, Nanyang, China. 25 The First Affiliated Hospital of Wannan Medical College, Wuhu, China. 26 Hunan Cancer Hospital, Changsha, China. 27 Anhui Provincial Cancer Hospital, Hefei, China. 28 The First Affiliated Hospital of Anhui Medical University, Hefei, China. 29 Meizhou People's Hospital, Meizhou, China. 30 Shandong Provincial Hospital, Jinan, China. 31 Shijiazhuang People's Hospital, Shijiazhuang, China. 32 The Affiliated Hospital of Qingdao University, Qingdao, China. 33 Xingtai People's Hospital, Xingtai, China. 34 Zhejiang Cancer Hospital, Hangzhou, China. 35 Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. 36 Hubei Cancer Hospital, Wuhan, China. 37 Xuzhou Central Hospital, Xuzhou, China. 38 The Third Bethune Hospital of Jilin University, Changchun, China. 39 The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China. 40 Zhoukou Central Hospital, Zhoukou, China. 41 Linfen Central Hospital, Linfen, China. 42 Sichuan Provincial People's Hospital, Chengdu, China. 43 Northern Jiangsu People's Hospital, Yangzhou, China. 44 The First Affiliated Hospital of The University of South China, Hengyang, China. 45 Weihai Municipal Hospital, Weihai, China. 46 West China Hospital of Sichuan University, Chengdu, China. 47 Yunnan Cancer Hospital, Kunming, China. 48 Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China. 49 Taizhou Hospital of Zhejiang Province, Linhai, China. 50 The First Hospital of China Medical University, Shenyang, China. 51 The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 52 Guangxi Medical University Cancer Hospital, Nanning, China. 53 The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China. 54 General Hospital of Northern Theater Command, Shenyang, China. 55 Shengjing Hospital of China Medical University, Shenyang, China. 56 Hengshui People's Hospital (Harrison International Peace Hospital), Hengshui, China. 57 Affiliated Hospital of Jiangsu University, Zhenjiang, China. 58 Weifang People's Hospital, Weifang, China. 59 The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China. 60 Fujian Medical University Union Hospital, Fuzhou, China. 61 Tianjin Medical University General Hospital, Tianjin, China. 62 Xiangya Hospital Central South University, Changsha, China. 63 Affiliated Hospital of Guilin Medical University, Guilin, China. 64 Hainan Cancer Hospital, Haikou, China. 65 Huai'an First People's Hospital, Huai'an, China. 66 Inner Mongolia Autonomous Region People's Hospital, Hohhot, China. 67 The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China. 68 Chifeng Municipal Hospital, Chifeng, China. 69 Cangzhou Central Hospital, Cangzhou, China. 70 Affiliated Hospital of Chengde Medical University, Chengde, China. 71 Daqing People's Hospital, Daqing, China. 72 Affiliated Hospital of Hebei University, Baoding, China. 73 The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. 74 Affiliated Hospital of Zunyi Medical University, Zunyi, China. 75 The Second Affiliated Hospital of Soochow University, Suzhou, China. 76 Yuebei People's Hospital, Shaoguan, China. 77 Akeso Biopharma Inc., Zhongshan, China. 78 University of California Los Angeles Health, Los Angeles, CA, USA. 79 Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA. 80 The Bloomberg~Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 81 State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing, China. jijiafu@hsc.pku.edu.cn.
- 刊名
- Nature medicine
- 年份
- 2025
- ISSN
- 1546-170X
- 文献类型
- 期刊
-
被引次数
-
收录
CPCI-S
PBU_D
Scopus